Products
This classification denotes coagulation factor VIII, a procoagulant component,a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 839MOZ74GK. European Medicines Agency schedules Antihemophilic Factor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13813MIG.
How AGI delivers it
Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
For Antihemophilic factor or globulin, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
Get the professional outcome delivered as software, priced on results, not headcount.
For Antihemophilic factor or globulin, get the professional outcome delivered as software, priced on results, not headcount.
Value flow
Go deeper